Datasets:

zexianli

/

nasdaq_data

like 0

2023-12-28

2023-12-27

2023-12-26

2023-12-22

2023-12-21

2023-12-20

2023-12-19

2023-12-18

2023-12-15

2023-12-14

2023-12-13

2023-12-12

Wolfe Research Initiates Coverage of Agilent Technologies (A) with Outperform Recommendation | Agilent Technologies Reaches Analyst Target Price

Agilent Technologies Declares $0.24 Dividend On November 15, 2023 the company declared a regular quarterly dividend of $0.24 per share ($0.94 annualized). In it's prior filing, the firm reported owning 11,037K shares, representing an increase of 0.35%. VTSMX - Vanguard Total Stock Market Index Fund Investor Shares holds 9,113K shares representing 3.12% ownership of the company. | When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level. There are 14 different analyst targets within the Zacks coverage universe contributing to that average for Agilent Technologies, Inc., but the average is just that — a mathematical average. » Current 1 Month Ago 2 Month Ago 3 Month Ago Strong buy ratings: 7 9 9 9 Buy ratings: 0 0 0 0 Hold ratings: 7 5 5 4 Sell ratings: 0 0 0 0 Strong sell ratings: 1 1 1 1 Average rating: 2.2 1.93 1.93 1.86 The average rating presented in the last row of the above table above is from 1 to 5 where 1 is Strong Buy and 5 is Strong Sell.

2023-12-11

2023-12-08

2023-12-07

Agilent (A) Enhances BioTek Cytation C10 With New Technology | Pre-Market Most Active for Dec 7, 2023 : SQQQ, PLTR, TQQQ, ALT, UBER, PFE, GILD, MRK, AMD, NIO, JBLU, AI

Agilent Technologies, Inc. Price and Consensus Agilent Technologies, Inc. price-consensus-chart | Agilent Technologies, Inc. Quote Growth Prospects The latest move positions the company well to strengthen its footing in the global microplate reader and live cell imaging markets. Zacks Rank & Stocks to Consider Currently, Agilent carries a Zacks Rank #4 (Sell). Click to get this free report Badger Meter, Inc. (BMI) : Free Stock Analysis Report Agilent Technologies, Inc. (A) : Free Stock Analysis Report Adobe Inc. (ADBE) : Free Stock Analysis Report Arista Networks, Inc. (ANET) : Free Stock Analysis Report To read this article on Zacks.com click here. | The total Pre-Market volume is currently 39,237,818 shares traded. Over the last four weeks they have had 6 up revisions for the earnings forecast, for the fiscal quarter ending Dec 2023. Over the last four weeks they have had 4 up revisions for the earnings forecast, for the fiscal quarter ending Mar 2024.

2023-12-06

2023-12-05

A Quantitative Stock Analysis

Detailed Analysis of AGILENT TECHNOLOGIES INC A Guru Analysis A Fundamental Analysis More Information on Partha Mohanram Partha Mohanram Portfolio About Partha Mohanram: Sometimes the best investing strategies don't come from the world of investing. His research paper "Separating Winners from Losers among Low Book-to-Market Stocks using Financial Statement Analysis" looked at the criteria that can be used to separate growth stocks that continue their upward trajectory from those that don't. Additional Research Links Top NASDAQ 100 Stocks Top Technology Stocks Top Large-Cap Growth Stocks High Momentum Stocks High Insider Ownership Stocks Financial Planning Podcast About Validea: Validea is aninvestment researchservice that follows the published strategies of investment legends.

2023-12-04

2023-12-01

2023-11-30

2023-11-29

2023-11-28

2023-11-27

2023-11-24

The Zacks Analyst Blog Highlights Visa, Marriott International, Parker-Hannifin, FedEx and Agilent Technologies

Here are highlights from Wednesday’s Analyst Blog: Top Research Reports for Visa, Marriott International and Parker-Hannifin The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Visa Inc., Marriott International, Inc. and Parker-Hannifin Corp. Click to get this free report Visa Inc. (V) : Free Stock Analysis Report Marriott International, Inc. (MAR) : Free Stock Analysis Report Parker-Hannifin Corporation (PH) : Free Stock Analysis Report Agilent Technologies, Inc. (A) : Free Stock Analysis Report FedEx Corporation (FDX) : Free Stock Analysis Report To read this article on Zacks.com click here.

2023-11-22

3 Biotech Stocks With Big-Time Breakthrough Potential | Top Research Reports for Visa, Marriott International & Parker-Hannifin

InvestorPlace - Stock Market News, Stock Advice & Trading Tips In a world in constant evolution and growth, more and more companies are needed that are committed to development and research in the health area. One positive aspect of the report is Agilent’s commitment to shareholders, as evidenced by the 5% increase in the quarterly dividend, reflecting confidence in the company’s financial position. Exact Sciences (EXAS) Source: Tada Images / Shutterstock Exact Sciences (NASDAQ:EXAS) stands out as a key player in the field of cancer detection and diagnostics, attracting the attention of investors seeking innovative opportunities. | If you want an email notification each time Sheraz publishes a new article, please click here>>> Today's Must Read Visa (V) Rides On Growing Cross Border Volume, Expenses High Solid Demand & Expansion Effort Aid Marriott (MAR), High Debt Ail Aerospace Systems Unit Aids Parker-Hannifin ( PH ), Costs Hurt Featured Reports FedEx (FDX) Benefits From Dividends & Buyback, Expenses Ail The Zacks analyst likes the shareholder-friendly measures adopted by FedEx. Click to get this free report Visa Inc. (V) : Free Stock Analysis Report Marriott International, Inc. (MAR) : Free Stock Analysis Report America Movil, S.A.B. de C.V. Unsponsored ADR (AMX) : Free Stock Analysis Report Parker-Hannifin Corporation (PH) : Free Stock Analysis Report Agilent Technologies, Inc. (A) : Free Stock Analysis Report FedEx Corporation (FDX) : Free Stock Analysis Report To read this article on Zacks.com click here.

2023-11-21

Tuesday Sector Leaders: Healthcare, Consumer Products | A Quantitative Stock Analysis | Agilent (A) Q4 Earnings & Revenues Beat Estimates, Down Y/Y | S&P 500 Movers: J, A | A Makes Bullish Cross Above Critical Moving Average

Among healthcare ETFs, one ETF following the sector is the Health Care Select Sector SPDR ETF (Symbol: XLV), which is up 0.8% on the day, and down 2.87% year-to-date. One ETF closely tracking Consumer Products stocks is the iShares U.S. Consumer Goods ETF (IYK), which is up 0.2% in midday trading, and down 5.05% on a year-to-date basis. Comparing these stocks and ETFs on a trailing twelve month basis, below is a relative stock price performance chart, with each of the symbols shown in a different color as labeled in the legend at the bottom: Here's a snapshot of how the S&P 500 components within the various sectors are faring in afternoon trading on Tuesday. | Detailed Analysis of AGILENT TECHNOLOGIES INC A Guru Analysis A Fundamental Analysis More Information on Partha Mohanram Partha Mohanram Portfolio About Partha Mohanram: Sometimes the best investing strategies don't come from the world of investing. His research paper "Separating Winners from Losers among Low Book-to-Market Stocks using Financial Statement Analysis" looked at the criteria that can be used to separate growth stocks that continue their upward trajectory from those that don't. Additional Research Links Top NASDAQ 100 Stocks Top Technology Stocks Top Large-Cap Growth Stocks High Momentum Stocks High Insider Ownership Stocks About Validea: Validea is aninvestment researchservice that follows the published strategies of investment legends. | Operating Results For the fiscal fourth quarter, gross margin in the LSAG segment contracted by 100 basis points (bps) to 59.6% from the prior-year fiscal quarter’s number. Guidance For the fiscal first quarter of 2024, management expects revenues of $1.555-$1.605 billion, suggesting a decline between 11.4% and 8.6% on a reported basis from the year-ago fiscal quarter’s actuals. Click to get this free report Salesforce Inc. (CRM) : Free Stock Analysis Report Badger Meter, Inc. (BMI) : Free Stock Analysis Report Agilent Technologies, Inc. (A) : Free Stock Analysis Report Arista Networks, Inc. (ANET) : Free Stock Analysis Report To read this article on Zacks.com click here. | In early trading on Tuesday, shares of Agilent Technologies, topped the list of the day's best performing components of the S&P 500 index, trading up 8.1%. And the worst performing S&P 500 component thus far on the day is Jacobs Solutions, trading down 5.5%. Two other components making moves today are Best Buy, trading down 4.1%, and Waters, trading up 5.0% on the day. | In trading on Tuesday, shares of Agilent Technologies, Inc. (Symbol: A) crossed above their 200 day moving average of $124.47, changing hands as high as $124.68 per share. The chart below shows the one year performance of A shares, versus its 200 day moving average: Looking at the chart above, A's low point in its 52 week range is $96.80 per share, with $160.265 as the 52 week high point — that compares with a last trade of $123.46. The A DMA information above was sourced from TechnicalAnalysisChannel.com Click here to find out which 9 other stocks recently crossed above their 200 day moving average » Also see: • MOK Historical Stock Prices • Top Ten Hedge Funds Holding SWM • AIT Dividend Growth Rate The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

2023-11-20

Agilent (A) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates | Agilent Technologies Q4 Profit Increases, beats estimates | After-Hours Earnings Report for November 20, 2023 : A, KEYS, ZM, BRBR, SYM, GBDC, CENTA, CENT, ENTA, XELB | Agilent Technologies Q4 23 Earnings Conference Call At 4:30 PM ET

Here is how Agilent performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts: Net Revenue- Americas: $702 million compared to the $678.42 million average estimate based on two analysts. Revenue by End Markets- Diagnostics and Clinical: $236 million compared to the $234.25 million average estimate based on two analysts. Revenue by End Markets- Pharmaceutical and Biopharmaceutical: $590 million compared to the $595.74 million average estimate based on two analysts. | (RTTNews) - Agilent Technologies (A) reported a profit for its fourth quarter that increased from the same period last year and beat the Street estimates. This compares with $368 million, or $1.23 per share, in last year's fourth quarter. Excluding items, Agilent Technologies reported adjusted earnings of $404 million or $1.38 per share for the period. | Zacks Investment Research reports that the 2023 Price to Earnings ratio for BRBR is 34.63 vs. an industry ratio of 5.30, implying that they will have a higher earnings growth than their competitors in the same industry. Zacks Investment Research reports that the 2023 Price to Earnings ratio for GBDC is 8.61 vs. an industry ratio of 7.80, implying that they will have a higher earnings growth than their competitors in the same industry. The consumer company's consensus earnings per share forecast from the 4 analysts that follow the stock is $0.08. | (RTTNews) - Agilent Technologies (A) will host a conference call at 4:30 PM ET on November 20, 2023, to discuss Q4 23 earnings results. To access the live webcast, log on to https://www.investor.agilent.com/news-and-events/events/default.aspx The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

2023-11-17

2023-11-16

Daily Dividend Report: CSCO,CB,EXR,NOC,A,PHM | What to Note Ahead of Agilent Technologies' (A) Q4 Earnings | Agilent (A) Boosts DGG Offerings With PD-L1 IHC 22C3 Approval

The Board of Directors of Chubb today declared a quarterly dividend equal to $0.86 per share, payable on January 5, 2024 to shareholders of record at the close of business on December 15, 2023. The board of directors of Northrop Grumman declared a quarterly dividend of $1.87 per share on Northrop Grumman common stock, payable Dec. 13, 2023, to shareholders of record as of the close of business Nov. 27, 2023. Agilent Technologies today announced the company has increased its quarterly dividend to 23.6 cents per share of common stock, a 5% increase over the previous dividend. | The Zacks Consensus Estimate for earnings is pegged at $1.34 per share, indicating a fall of 12.4% from the year-ago fiscal quarter’s reported figure. Agilent Technologies, Inc. Price and EPS Surprise Agilent Technologies, Inc. price-eps-surprise | Agilent Technologies, Inc. Quote Factors to Note The company is expected to have gained from growing momentum across Agilent’s Cross Lab Group (“ACG”) and Diagnostics and Genomics Group (“DGG”) segments during the fiscal fourth quarter. Click to get this free report Agilent Technologies, Inc. (A) : Free Stock Analysis Report Costco Wholesale Corporation (COST) : Free Stock Analysis Report Synopsys, Inc. (SNPS) : Free Stock Analysis Report Snowflake Inc. (SNOW) : Free Stock Analysis Report To read this article on Zacks.com click here. | Agilent Technologies, Inc. Price and Consensus Agilent Technologies, Inc. price-consensus-chart | Agilent Technologies, Inc. Quote Growth Prospects The latest announcement bodes well for the company’s deepening focus to strengthen its footprint in the PD-1 and PD-L1 inhibitors market. Notably, Agilent signed a Research Collaboration Agreement with the National Cancer Centre Singapore to expedite translational cancer research on Asian-prevalent cancer genomics over two years. Click to get this free report Salesforce Inc. (CRM) : Free Stock Analysis Report Badger Meter, Inc. (BMI) : Free Stock Analysis Report Agilent Technologies, Inc. (A) : Free Stock Analysis Report Arista Networks, Inc. (ANET) : Free Stock Analysis Report To read this article on Zacks.com click here.

2023-11-15

2023-11-14

Agilent Technologies Announces FDA Approval For PD-L1 IHC 22C3 PharmDx - Quick Facts

(RTTNews) - Agilent Technologies Inc. (A) has received FDA approval for the use of PD-L1 IHC 22C3 pharmDx as a diagnostic tool to aid in identifying patients with Gastric or Gastroesophageal Junction Adenocarcinoma who may be eligible for treatment with KEYTRUDA, Merck's anti-PD-1 therapy. For More Such Health News, visit rttnews.com. The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

2023-11-13

Analysts Estimate Agilent Technologies (A) to Report a Decline in Earnings: What to Look Out for

The Zacks Earnings ESP compares the Most Accurate Estimate to the Zacks Consensus Estimate for the quarter; the Most Accurate Estimate is a more recent version of the Zacks Consensus EPS estimate. Our research shows that it is difficult to predict an earnings beat with any degree of confidence for stocks with negative Earnings ESP readings and/or Zacks Rank of 4 (Sell) or 5 (Strong Sell). For Agilent, the Most Accurate Estimate is lower than the Zacks Consensus Estimate, suggesting that analysts have recently become bearish on the company's earnings prospects.

2023-11-10

2023-11-09

2023-11-08

Agilent Technologies (A) Stock Dips While Market Gains: Key Facts

The Zacks Rank system, stretching from #1 (Strong Buy) to #5 (Strong Sell), has a noteworthy track record of outperforming, validated by third-party audits, with stocks rated #1 producing an average annual return of +25% since the year 1988. This industry, currently bearing a Zacks Industry Rank of 95, finds itself in the top 38% echelons of all 250+ industries. The Zacks Industry Rank assesses the strength of our separate industry groups by calculating the average Zacks Rank of the individual stocks contained within the groups.

2023-11-07

A Quantitative Stock Analysis

Detailed Analysis of AGILENT TECHNOLOGIES INC A Guru Analysis A Fundamental Analysis More Information on Partha Mohanram Partha Mohanram Portfolio About Partha Mohanram: Sometimes the best investing strategies don't come from the world of investing. His research paper "Separating Winners from Losers among Low Book-to-Market Stocks using Financial Statement Analysis" looked at the criteria that can be used to separate growth stocks that continue their upward trajectory from those that don't. Additional Research Links Top NASDAQ 100 Stocks Top Technology Stocks Top Large-Cap Growth Stocks High Momentum Stocks High Insider Ownership Stocks About Validea: Validea is aninvestment researchservice that follows the published strategies of investment legends.

2023-11-06

2023-11-03

2023-11-02

2023-11-01

Agilent Technologies (A) Stock Dips While Market Gains: Key Facts

This industry, currently bearing a Zacks Industry Rank of 34, finds itself in the top 14% echelons of all 250+ industries. The Zacks Industry Rank evaluates the power of our distinct industry groups by determining the average Zacks Rank of the individual stocks forming the groups. 7 Best Stocks for the Next 30 Days Just released: Experts distill 7 elite stocks from the current list of 220 Zacks Rank #1 Strong Buys.

2023-10-31

Ametek (AME) Q3 Earnings Surpass Estimates

Ametek (AME) came out with quarterly earnings of $1.64 per share, beating the Zacks Consensus Estimate of $1.58 per share. Ametek, which belongs to the Zacks Electronics - Testing Equipment industry, posted revenues of $1.62 billion for the quarter ended September 2023, missing the Zacks Consensus Estimate by 1.55%. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #2 (Buy) for the stock.

2023-10-30

Oversold Conditions For Agilent Technologies (A)

In trading on Monday, shares of Agilent Technologies, Inc. (Symbol: A) entered into oversold territory, hitting an RSI reading of 25.5, after changing hands as low as $96.80 per share. The chart below shows the one year performance of A shares: Looking at the chart above, A's low point in its 52 week range is $96.80 per share, with $160.265 as the 52 week high point — that compares with a last trade of $98.86. Find out what 9 other oversold stocks you need to know about » Also see: • Cheap Materials Shares • SI Stock Predictions • TPL Stock Predictions The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

2023-10-27

2023-10-26

2023-10-25

2023-10-24

A Quantitative Stock Analysis | Danaher beats profit estimates on respiratory testing demand

Detailed Analysis of AGILENT TECHNOLOGIES INC A Guru Analysis A Fundamental Analysis More Information on Partha Mohanram Partha Mohanram Portfolio About Partha Mohanram: Sometimes the best investing strategies don't come from the world of investing. His research paper "Separating Winners from Losers among Low Book-to-Market Stocks using Financial Statement Analysis" looked at the criteria that can be used to separate growth stocks that continue their upward trajectory from those that don't. Additional Research Links Top NASDAQ 100 Stocks Top Technology Stocks Top Large-Cap Growth Stocks High Momentum Stocks High Insider Ownership Stocks About Validea: Validea is aninvestment researchservice that follows the published strategies of investment legends. | Oct 24 (Reuters) - Danaher DHR.N on Tuesday beat Wall Street estimates for third-quarter profit as strong demand for its diagnostic tests for respiratory diseases helped soften the blow from weaker sales at the healthcare conglomerate's life-sciences unit. The diagnostics unit, which makes kits, also used for COVID-19 testing, as well as reagents and other tools, reported sales of $2.25 billion, beating the average analyst estimate of $2.12 billion, according to LSEG data. However, the life sciences unit, which provides reagents and lab equipment used in the discovery of new drugs and vaccines, posted sales of $1.71 billion, missing estimates of $1.78 billion.

2023-10-23

2023-10-20

2023-10-19

December 15th Options Now Available For Agilent Technologies (A)

The current analytical data (including greeks and implied greeks) suggest the current odds of that happening are 99%. Below is a chart showing the trailing twelve month trading history for Agilent Technologies, Inc., and highlighting in green where the $105.00 strike is located relative to that history: Turning to the calls side of the option chain, the call contract at the $110.00 strike price has a current bid of $4.50. Below is a chart showing A's trailing twelve month trading history, with the $110.00 strike highlighted in red: Considering the fact that the $110.00 strike represents an approximate 1% premium to the current trading price of the stock (in other words it is out-of-the-money by that percentage), there is also the possibility that the covered call contract would expire worthless, in which case the investor would keep both their shares of stock and the premium collected.

2023-10-18

2023-10-17

Carl Icahn sues Illumina board for violating 'fiduciary duties'

Changes source in headline, recasts paragraph 1, adds background in paragraphs 4-6 Oct 17 (Reuters) - Activist-investor Carl Icahn sued the board of directors at genetic testing company Illumina ILMN.O and accused them of breaching their fiduciary duties, according to a sealed copy of the complaint on Tuesday. The publicly available version of the complaint did not contain further details, but Icahn told the 13D investor conference in New York on Tuesday that the lawsuit pertained to Illumina completing its acquisition of cancer detection test maker Grail. The gene-sequencing machine maker had repurchased Grail in 2021 despite opposition from U.S. and European antitrust regulators - a decision that prompted Icahn to pursue a proxy fight at Illumina, arguing Grail should be divested as it had cost investors billions of dollars.

2023-10-16

2023-10-13

2023-10-12

2023-10-11

2023-10-10

Agilent (A) Bolsters NTD Research With SIDC Partnership

Agilent Technologies, Inc. Price and Consensus Agilent Technologies, Inc. price-consensus-chart | Agilent Technologies, Inc. Quote Growth Prospects We believe that the latest move will strengthen the company’s footing in the global neglected tropical diseases diagnosis market. Further, Agilent Technologies introduced new liquid chromatography mass spectrometry systems, Agilent 6495D LC/TQ and Revident LC/Q-TOF, along with new software for profiling and library management, ensuring high analytical sensitivity and efficiency for fast, high-quality data and early maintenance feedback for optimal performance. Click to get this free report Agilent Technologies, Inc. (A) : Free Stock Analysis Report Applied Materials, Inc. (AMAT) : Free Stock Analysis Report Asure Software Inc (ASUR) : Free Stock Analysis Report Arista Networks, Inc. (ANET) : Free Stock Analysis Report To read this article on Zacks.com click here.

2023-10-09

2023-10-06

2023-10-05

Q4 Stock Predictions: 3 S&P 500 Stocks Ready to Soar

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Stocks ended the third quarter on a sour note. Charles River Laboratories (CRL) Source: IgorGolovniov / Shutterstock.com Charles River Laboratories (NYSE:CRL) is a leading healthcare company focused on providing lab tools and services related to pharmaceutical drug development. Keysight Technologies (KEYS) Source: Funtap / Shutterstock.com Keysight Technologies (NYSE:KEYS) is a company that provides testing, product quality, and design solutions to technology companies.

2023-10-04

2023-10-03

2023-10-02

2023-09-29

Barclays Maintains Agilent Technologies (A) Underweight Recommendation

VTSMX - Vanguard Total Stock Market Index Fund Investor Shares holds 9,177K shares representing 3.14% ownership of the company. In it's prior filing, the firm reported owning 12,057K shares, representing a decrease of 38.01%. In it's prior filing, the firm reported owning 8,219K shares, representing a decrease of 2.05%.

2023-09-28

Ex-Dividend Reminder: Upbound Group, Cardinal Health and Agilent Technologies

Looking at the universe of stocks we cover at Dividend Channel, on 10/2/23, Upbound Group Inc (Symbol: UPBD), Cardinal Health, Inc. (Symbol: CAH), and Agilent Technologies, Inc. (Symbol: A) will all trade ex-dividend for their respective upcoming dividends. Upbound Group Inc will pay its quarterly dividend of $0.34 on 10/24/23, Cardinal Health, Inc. will pay its quarterly dividend of $0.5006 on 10/15/23, and Agilent Technologies, Inc. will pay its quarterly dividend of $0.225 on 10/25/23. If they do continue, the current estimated yields on annualized basis would be 4.58% for Upbound Group Inc, 2.27% for Cardinal Health, Inc., and 0.81% for Agilent Technologies, Inc.. Free Report: Top 8%+ Dividends (paid monthly) In Thursday trading, Upbound Group Inc shares are currently up about 0.9%, Cardinal Health, Inc. shares are up about 0.3%, and Agilent Technologies, Inc. shares are up about 0.3% on the day.

2023-09-27

2023-09-26

2023-09-25

After Hours Most Active for Sep 25, 2023 : OKE, APO^A, ET, XPEV, BAC, FINV, MCHI, ARM, CSCO, CMCSA, QQQ, AAPL

The total After hours volume is currently 63,813,936 shares traded. Arm Holdings plc (ARM) is -0.14 at $54.30, with 1,625,772 shares traded. Comcast Corporation (CMCSA) is unchanged at $44.87, with 1,323,937 shares traded.

2023-09-22

2023-09-21

Daily Dividend Report: CLX,CVX,A,SBUX,AMT | Agilent Technologies is Now Oversold (A)

Agilent Technologies, today announced that a quarterly dividend of 22.5 cents per share of common stock will be paid on Oct. 25, 2023, to all shareholders of record as of the close of business on Oct. 3, 2023. Starbucks today announced that its Board of Directors approved an increase in the company's quarterly cash dividend from $0.53 to $0.57 per share of outstanding Common Stock. This increase will be effective with the dividend payable on November 24, 2023, to shareholders of record on November 10, 2023, and raises the company's annual dividend rate to $2.28 per share. | In trading on Thursday, shares of Agilent Technologies, Inc. (Symbol: A) entered into oversold territory, hitting an RSI reading of 26.2, after changing hands as low as $109.905 per share. The chart below shows the one year performance of A shares: Looking at the chart above, A's low point in its 52 week range is $109 per share, with $160.265 as the 52 week high point — that compares with a last trade of $110.56. Find out what 9 other oversold stocks you need to know about » Also see: • Stocks Being Sold By Hedge Funds • LII Average Annual Return • ESP Past Earnings The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

2023-09-20

Agilent (A) Boosts Genomic Profiling With New Collaboration

Agilent Technologies, Inc. Price and Consensus Agilent Technologies, Inc. price-consensus-chart | Agilent Technologies, Inc. Quote Growth Prospects The latest partnership is in sync with the company’s efforts to strengthen its footprint in the global genomics market. While Asure Software sports a Zacks Rank #1 (Strong Buy), Arista Networks and Applied Materials carry a Zacks Rank #2 (Buy) each. Click to get this free report Agilent Technologies, Inc. (A) : Free Stock Analysis Report Applied Materials, Inc. (AMAT) : Free Stock Analysis Report Asure Software Inc (ASUR) : Free Stock Analysis Report Arista Networks, Inc. (ANET) : Free Stock Analysis Report To read this article on Zacks.com click here.

2023-09-19

2023-09-18

2023-09-15

Notable Friday Option Activity: PRGS, POOL, A | Friday Sector Leaders: Utilities, Healthcare

Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Progress Software Corp (Symbol: PRGS), where a total of 1,216 contracts have traded so far, representing approximately 121,600 underlying shares. Below is a chart showing PRGS's trailing twelve month trading history, with the $50 strike highlighted in orange: Pool Corp (Symbol: POOL) saw options trading volume of 1,502 contracts, representing approximately 150,200 underlying shares or approximately 53.3% of POOL's average daily trading volume over the past month, of 282,025 shares. Below is a chart showing POOL's trailing twelve month trading history, with the $360 strike highlighted in orange: And Agilent Technologies, Inc. (Symbol: A) saw options trading volume of 8,847 contracts, representing approximately 884,700 underlying shares or approximately 52.8% of A's average daily trading volume over the past month, of 1.7 million shares. | Within the sector, DTE Energy Co (Symbol: DTE) and CenterPoint Energy, Inc (Symbol: CNP) are two of the day's stand-outs, showing a gain of 0.8% and 0.8%, respectively. Among utilities ETFs, one ETF following the sector is the Utilities Select Sector SPDR ETF (Symbol: XLU), which is down 0.1% on the day, and down 6.10% year-to-date. One ETF closely tracking Healthcare stocks is the Health Care Select Sector SPDR ETF (XLV), which is down 0.5% in midday trading, and down 1.36% on a year-to-date basis.

2023-09-14

Agilent (A) Down 6.5% Since Last Earnings Report: Can It Rebound?

DGG: Revenues increased 3% from the prior-year fiscal quarter’s figure on a reported as well as a core basis to $349 million, accounting for the remaining 21% of total revenues. Operating Results For the fiscal third quarter, gross margin in the LSAG segment contracted by 50 basis points (bps) to 29.9% from the prior-year fiscal quarter’s number. Guidance For the fiscal fourth quarter of 2023, management expects revenues of $1.655-$1.705 billion, suggesting a decline between 12.2% and 9.5% on a core basis from the year-ago fiscal quarter’s actuals.

2023-09-13

2023-09-12

Agilent To Sell Resolution Bioscience To Exact Sciences For Undisclosed Sum

(RTTNews) - Agilent Technologies, Inc. (A) and Exact Sciences Corp. (EXAS) said on Tuesday that they have inked a deal for the sale of Resolution Bioscience to Exact Sciences., for an undisclosed sum. Sam Raha, Senior Vice President at Agilent, said: "Exact is a leading centralized laboratory for advanced cancer diagnostic testing with significant capabilities and resources in this area, which makes Resolution Bioscience a strategic fit for them. This agreement will enable the talented Resolution Bioscience team to continue their work advancing diagnostic solutions for their customers and patients, a very positive outcome of this transaction."

2023-09-11

2023-09-08

2023-09-07

2023-09-06

2023-09-05

Illumina names Agilent exec Jacob Thaysen as CEO

Adds background in paragraphs 2-3 Sept 5 (Reuters) - Illumina Inc ILMN.O said on Tuesday its board has named Agilent Technologies' A.N executive Jacob Thaysen as the U.S. genetic testing company's CEO. The appointment comes months after Illumina's former CEO Francis deSouza stepped down, marking a victory for activist investor Carl Icahn. (Reporting by Manas Mishra and Bhanvi Satija in Bengaluru; Editing by Shilpi Majumdar) ((Manas.Mishra@thomsonreuters.com; www.twitter.com/Manaswrites15;)) The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

2023-09-01

Do Options Traders Know Something About Agilent (A) Stock We Don't?

Options with high levels of implied volatility suggest that investors in the underlying stocks are expecting a big move in one direction or the other. Oftentimes, options traders look for options with high levels of implied volatility to sell premium. Click to see the trades now >> Zacks Names "Single Best Pick to Double" From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come.

2023-08-31

Building Wealth with Spinoffs: How Adding These Gems Can Transform Your Portfolio

In a Spinoff, a parent company separates one of its business entities or divisions into a standalone, independent company. The new enterprise that emerges because of a Spinoff is often referred to as a "Spinoff company." Why the dynamics of Spinoffs make it an essential area for an investor to analyze: Studies have shown that Spinoffs have historically beaten the market by over 10 percent as the pure, newly focused business takes off.

2023-08-30

2023-08-29

2023-08-28

2023-08-25

EXCLUSIVE-Danaher in the lead to acquire biomedical equipment vendor Abcam -sources | EXCLUSIVE-Danaher in the lead to acquire biomedical equipment vendor Abcam-sources

By David Carnevali NEW YORK, Aug 25 (Reuters) - Danaher Corp DHR.N is in the lead to acquire Abcam Plc ABCM.O, a provider of supplies to life science researchers with a market value of $5.4 billion, as it expands its biomedical offerings, people familiar with the matter said on Friday. Abcam believes that Danaher's all-cash offer is superior to a rival bid from Agilent Technologies Inc A.N, the sources said. One of the sources said the deal price would be close to Abcam's current valuation, given that its stock has already risen more than 20% after Bloomberg News reported on June 16 that the company was fielding takeover interest. | By David Carnevali NEW YORK, Aug 25 (Reuters) - Danaher Corp DHR.N is in the lead to acquire Abcam Plc ABCM.O, a provider of supplies to life science researchers with a market value of $5.1 billion, as it expands its biomedical offerings, people familiar with the matter said on Friday. Abcam believes that Danaher's all-cash offer is superior to a rival bid from Agilent Technologies Inc A.N, the sources said. One of the sources said the deal price would be close to Abcam's current valuation, given that its stock has already risen close to 20% after Bloomberg News reported on June 16 that the company was fielding takeover interest.

2023-08-24

2023-08-23

2023-08-22

2023-08-21

Buy the Drop: 3 Stocks to Snag After This Month’s 20% Tumble

InvestorPlace - Stock Market News, Stock Advice & Trading Tips August has been a great month for investors looking for bargain stocks to buy on the dip. In the meantime, a quick screen of S&P 500 stocks down more than 20% over the past month gives bargain-hunting investors 14 stocks to choose from. We continue to see strong growth in both the U.S. business where provider resupply programs have augmented growth and in our markets outside the U.S. where our consumer outreach and subscription programs are also driving mass replenishment directly with those end user patients.” Of the 24 analysts covering the stock, 18 rate it Overweight or an outright Buy with a $240 median price, 45% higher than its current share price.

2023-08-18

These 3 Unusually Active Options Have 1 Thing in Common

Over the past year, Agilent stock hasn’t traded that low, with a 52-week low of $113.28. “This cathode facility will supply the material that goes into Ford’s future EVs in North America, specifically some of our future trucks,” Lisa Drake, Ford vice president for EVs, told reporters. More Options News from Barchart Walmart's Better Than Expected Earnings and FCF Could Push WMT Stock Higher Here’s the Real Lowdown of Ross Stores’ (ROST) Q2 Report Somebody Really Must Like Suncor Given Its Unusual Options Activity Attention Speculators: Going Long Discover Financial Services (DFS) Might Not Be a Bad Idea On the date of publication, Will Ashworth did not have (either directly or indirectly) positions in any of the securities mentioned in this article.

2023-08-17

Stocks Move Higher Before the Open as Investors Weigh Fed Minutes, Walmart Earnings on Tap

The minutes of the Federal Open Market Committee’s July 25-26 meeting revealed a split among Fed officials regarding the necessity for further interest rate hikes, as “some participants” voiced concerns about potential economic risks from excessive rate increases, while “most” policymakers continued to prioritize the battle against inflation. Japan’s Nikkei 225 Stock Index closed lower today as worries about more U.S. Federal Reserve interest rate hikes and a gloomy outlook for China’s economy weighed on market sentiment. More Stock Market News from Barchart 3 Dividend Kings To Buy And Hold Forever in a Retirement PortfolioStocks Fall and Bond Yields Climb as Fed Remains Hawkish2 Energy Stocks Wall Street Predicts Will Rally 25% or MoreUnusual Activity in DraftKings Put Options Shows Traders Are Bullish On the date of publication, Oleksandr Pylypenko did not have (either directly or indirectly) positions in any of the securities mentioned in this article.

2023-08-16

TD Cowen Maintains Agilent Technologies (A) Outperform Recommendation | Stocks Mixed as Markets Await Minutes of the July FOMC Meeting | Jefferies Maintains Agilent Technologies (A) Buy Recommendation | Stocks Fall and Bond Yields Climb as Fed Remains Hawkish | Wednesday Sector Laggards: Healthcare, Consumer Products | Credit Suisse Maintains Agilent Technologies (A) Outperform Recommendation | Evercore ISI Group Maintains Agilent Technologies (A) In-Line Recommendation | Barclays Maintains Agilent Technologies (A) Underweight Recommendation | Baird Maintains Agilent Technologies (A) Outperform Recommendation | Stocks Slightly Higher as Markets Await Minutes of the July FOMC Meeting | JP Morgan Maintains Agilent Technologies (A) Overweight Recommendation

Agilent Technologies Declares $0.22 Dividend On May 17, 2023 the company declared a regular quarterly dividend of $0.22 per share ($0.90 annualized). VTSMX - Vanguard Total Stock Market Index Fund Investor Shares holds 9,160K shares representing 3.10% ownership of the company. WELLS FARGO BANK, NATIONAL ASSOCIATION, as Syndicati Agilent Reports Second-Quarter Fiscal Year 2023 Financial Results Delivers solid results; adjusts full-year guidance in an increasingly challenging market Amended and Restated Bylaws of Agilent Technologies, Inc., incorporated by reference to Exhibit 3. | MarketAxcess Holdings (MKTX) is up more than +3% on signs of insider buying after an SEC filing showed CEO Concannon purchased $1.02 million of shares on Monday. Sep T-notes today are slightly higher on a decline in inflation expectations after the 10-year breakeven inflation rate fell to a 3-1/2 week low today at 2.308%. Silver prices are finding support on signs of strength in industrial metals demand after today’s news showed Eurozone Jun industrial production and U.S. Jul manufacturing production rose more than expected. | Agilent Technologies Declares $0.22 Dividend On May 17, 2023 the company declared a regular quarterly dividend of $0.22 per share ($0.90 annualized). VTSMX - Vanguard Total Stock Market Index Fund Investor Shares holds 9,160K shares representing 3.10% ownership of the company. Additional reading: Agilent Reports Third-Quarter Fiscal Year 2023 Financial Results Delivers on Q3; adjusts full-year outlook to reflect softer market conditions CREDIT AGREEMENT dated as of June 7, 2023 AGILENT TECHNOLOGIES, INC., The LENDERS Party Hereto, BNP PARIBAS, as Administrative Agent, CITIBANK, N.A., BANK OF AMERICA, N.A. | What you need to know… The S&P 500 Index ($SPX) (SPY) Wednesday closed down -0.76%, the Dow Jones Industrials Index ($DOWI) (DIA) closed down -0.52%, and the Nasdaq 100 Index ($IUXX) (QQQ) closed down -1.07%. The yuan fell to a 9-1/4 month low Wednesday, and the Shanghai Composite closed down -0.82% after China’s July home sales fell for the second month by the most in 7 months. Across the markets… September 10-year T-notes (ZNU23) Wednesday closed down -6.5 ticks, and the 10-year T-note yield rose +5.5 bp to 4.266%. | Among healthcare ETFs, one ETF following the sector is the Health Care Select Sector SPDR ETF (Symbol: XLV), which is flat on the day on the day, and up 0.85% year-to-date. One ETF closely tracking Consumer Products stocks is the iShares U.S. Consumer Goods ETF (IYK), which is down 0.1% in midday trading, and down 0.41% on a year-to-date basis. Utilities +0.7% Financial -0.0% Consumer Products -0.3% Services -0.3% Technology & Communications -0.3% Industrial -0.3% Materials -0.3% Energy -0.3% Healthcare -0.6% 10 ETFs With Stocks That Insiders Are Buying » Also see: • STRT market cap history • Top Ten Hedge Funds Holding SGNT • CE YTD Return The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc. | Agilent Technologies Declares $0.22 Dividend On May 17, 2023 the company declared a regular quarterly dividend of $0.22 per share ($0.90 annualized). VTSMX - Vanguard Total Stock Market Index Fund Investor Shares holds 9,160K shares representing 3.10% ownership of the company. WELLS FARGO BANK, NATIONAL ASSOCIATION, as Syndicati Agilent Reports Second-Quarter Fiscal Year 2023 Financial Results Delivers solid results; adjusts full-year guidance in an increasingly challenging market Amended and Restated Bylaws of Agilent Technologies, Inc., incorporated by reference to Exhibit 3. | Agilent Technologies Declares $0.22 Dividend On May 17, 2023 the company declared a regular quarterly dividend of $0.22 per share ($0.90 annualized). VTSMX - Vanguard Total Stock Market Index Fund Investor Shares holds 9,160K shares representing 3.10% ownership of the company. Additional reading: Agilent Reports Third-Quarter Fiscal Year 2023 Financial Results Delivers on Q3; adjusts full-year outlook to reflect softer market conditions CREDIT AGREEMENT dated as of June 7, 2023 AGILENT TECHNOLOGIES, INC., The LENDERS Party Hereto, BNP PARIBAS, as Administrative Agent, CITIBANK, N.A., BANK OF AMERICA, N.A. | Agilent Technologies Declares $0.22 Dividend On May 17, 2023 the company declared a regular quarterly dividend of $0.22 per share ($0.90 annualized). VTSMX - Vanguard Total Stock Market Index Fund Investor Shares holds 9,160K shares representing 3.10% ownership of the company. WELLS FARGO BANK, NATIONAL ASSOCIATION, as Syndicati Agilent Reports Second-Quarter Fiscal Year 2023 Financial Results Delivers solid results; adjusts full-year guidance in an increasingly challenging market Amended and Restated Bylaws of Agilent Technologies, Inc., incorporated by reference to Exhibit 3. | Agilent Technologies Declares $0.22 Dividend On May 17, 2023 the company declared a regular quarterly dividend of $0.22 per share ($0.90 annualized). VTSMX - Vanguard Total Stock Market Index Fund Investor Shares holds 9,160K shares representing 3.10% ownership of the company. WELLS FARGO BANK, NATIONAL ASSOCIATION, as Syndicati Agilent Reports Second-Quarter Fiscal Year 2023 Financial Results Delivers solid results; adjusts full-year guidance in an increasingly challenging market Amended and Restated Bylaws of Agilent Technologies, Inc., incorporated by reference to Exhibit 3. | Lower T-note yields and a decline in inflation expectations support stocks today. MarketAxcess Holdings (MKTX) is up more than +3% on signs of insider buying after an SEC filing showed CEO Concannon purchased $1.02 million of shares on Monday. Sep T-notes today are slightly higher on a decline in inflation expectations after the 10-year breakeven inflation rate fell to a 3-1/2 week low today at 2.308%. | Agilent Technologies Declares $0.22 Dividend On May 17, 2023 the company declared a regular quarterly dividend of $0.22 per share ($0.90 annualized). VTSMX - Vanguard Total Stock Market Index Fund Investor Shares holds 9,160K shares representing 3.10% ownership of the company. WELLS FARGO BANK, NATIONAL ASSOCIATION, as Syndicati Agilent Reports Second-Quarter Fiscal Year 2023 Financial Results Delivers solid results; adjusts full-year guidance in an increasingly challenging market Amended and Restated Bylaws of Agilent Technologies, Inc., incorporated by reference to Exhibit 3.

2023-08-15

Agilent Technologies Q3 23 Earnings Conference Call At 4:30 PM ET | Markets Remain Sold; H&R Block (HRB), Agilent (A) Beat | Agilent (A) Reports Q3 Earnings: What Key Metrics Have to Say | Agilent Technologies cuts annual forecasts on China weakness | After-Hours Earnings Report for August 15, 2023 : ALC, A, NU, JKHY, HRB, DLO, MRCY, LRN, DADA, KTCC, GBNH | Stock Index Futures Plunge on Pressure from Rising Bond Yields, China Data Disappoints | Agilent Technologies Q3 Profit Decreases, but beats estimates

(RTTNews) - Agilent Technologies (A) will host a conference call at 4:30 PM ET on August 15, 2023, to discuss Q3 23 earnings results. To access the live webcast, log on to https://www.investor.agilent.com/news-and-events/events/default.aspx The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc. | H&R Block HRB beat earnings estimates for its fiscal Q4 this afternoon, reporting earnings of $2.05 per share on $1.03 billion which outpaced expectations of $1.89 per share and $1.01 billion, respectively. Agilent Technologies A also released better-than-expected results for its fiscal Q3 after today’s close, with earnings of $1.43 per share stepping beyond the $1.37 analysts were expecting (and better than the $1.34 per share reported in the year-ago quarter), and revenues of $1.67 billion squeaking past the $1.66 billion in the Zacks consensus. Click to get this free report Target Corporation (TGT) : Free Stock Analysis Report Cisco Systems, Inc. (CSCO) : Free Stock Analysis Report Agilent Technologies, Inc. (A) : Free Stock Analysis Report H&R Block, Inc. (HRB) : Free Stock Analysis Report To read this article on Zacks.com click here. | Here is how Agilent performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts: Net Revenue- Americas: $667 million versus the two-analyst average estimate of $628.95 million. Revenue by End Markets- Academia and Government: $146 million compared to the $139.40 million average estimate based on two analysts. Revenue by End Markets- Diagnostics and Clinical: $241 million versus $241.46 million estimated by two analysts on average. | By Pratik Jain Aug 15 (Reuters) - Medical equipment maker Agilent Technologies A.N cut annual profit and sales forecasts for a second straight quarter as demand stays soft in major market China due to a slow economic recovery. Agilent expects full-year revenue to be between $6.80 billion and $6.85 billion, compared with $6.93 billion to $7.03 billion projected earlier. The company said on Tuesday it has taken a $291 million pre-tax charge in the quarter associated with the shutdown and expects the wind-down to continue through the fourth quarter and into early fiscal 2024. | Zacks Investment Research reports that the 2023 Price to Earnings ratio for ALC is 30.88 vs. an industry ratio of -60.00, implying that they will have a higher earnings growth than their competitors in the same industry. Zacks Investment Research reports that the 2023 Price to Earnings ratio for NU is 46.71 vs. an industry ratio of -3.60, implying that they will have a higher earnings growth than their competitors in the same industry. Zacks Investment Research reports that the 2023 Price to Earnings ratio for JKHY is 35.38 vs. an industry ratio of 17.90, implying that they will have a higher earnings growth than their competitors in the same industry. | September S&P 500 futures (ESU23) are down -0.61%, and September Nasdaq 100 E-Mini futures (NQU23) are down -0.48% this morning as market participants digested the latest U.K. employment data, which fueled concerns about inflationary pressures and consequently pushed U.S. Treasury yields higher, while disappointing economic data from China also weighed on sentiment ahead of crucial U.S. retail sales data. You can see more pre-market stock movers here Today’s U.S. Earnings Spotlight: Tuesday - August 15th Home Depot (HD), Suncor Energy (SU), Alcon (ALC), Agilent Technologies (A), Nu Holdings (NU), Sea (SE), Cardinal Health (CAH), Legend Bio (LEGN), Jack Henry&Associates (JKHY), Tencent Music Entertainment Group (TME), Coherent (COHR), CAVA Group (CAVA), H&R Block (HRB), Dlocal (DLO), IHS Holding (IHS), Mercury (MRCY), Stride (LRN), Dada Nexus (DADA), Riskified (RSKD), HUYA (HUYA), Eagle Point Cred (ECC), Mondee Holdings (MOND), International General Insurance (IGIC), GigaCloud Technology (GCT), Terran Orbital (LLAP), Rekor Systems (REKR). More Stock Market News from Barchart Strength in Chip Stocks Lifts the Overall MarketGeneral Mills vs. Kraft Heinz: Which is the Better Consumer Defensive Stock?Should You Buy the Dip in Apple Stock?Why Is Warren Buffett Selling U.S. Stocks? | (RTTNews) - Agilent Technologies (A) revealed a profit for third quarter that decreased from last year but beat the Street estimates. Excluding items, Agilent Technologies reported adjusted earnings of $422 million or $1.43 per share for the period. -Guidance: Full year EPS guidance: $5.40 - $5.43 Full year revenue guidance: $6.80 - $6.85 Bln The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

2023-08-14

Validea Detailed Fundamental Analysis - A | Stocks Set to Open Lower as Investors Await FOMC Minutes, Retail Earnings | Stocks Set to Open Higher as Investors Await FOMC Minutes, Retail Earnings

Detailed Analysis of AGILENT TECHNOLOGIES INC A Guru Analysis A Fundamental Analysis More Information on Partha Mohanram Partha Mohanram Portfolio About Partha Mohanram: Sometimes the best investing strategies don't come from the world of investing. His research paper "Separating Winners from Losers among Low Book-to-Market Stocks using Financial Statement Analysis" looked at the criteria that can be used to separate growth stocks that continue their upward trajectory from those that don't. Additional Research Links Top NASDAQ 100 Stocks Top Technology Stocks Top Large-Cap Growth Stocks High Momentum Stocks High Insider Ownership Stocks Excess Returns Investing Podcast About Validea: Validea is aninvestment researchservice that follows the published strategies of investment legends. | In the coming week, investors will be monitoring a spate of economic data, including U.S. Retail Sales, Core Retail Sales, Export Price Index, Import Price Index, NY Empire State Manufacturing Index, Building Permits (preliminary), Housing Starts, Industrial Production, Manufacturing Production, Crude Oil Inventories, Philadelphia Fed Manufacturing Index, and Initial Jobless Claims. United States Steel Corporation (X) surged over +22% in pre-market trading as the company initiated a formal review of its strategic options after rejecting a $7.25 billion cash and stock takeover offer from Cleveland-Cliffs Inc. CF Industries Holdings Inc (CF) slid more than -1% in pre-market trading after Barclays downgraded the stock to Equal Weight from Overweight. More Stock Market News from Barchart Retail Data, FOMC and Other Can't Miss Items this WeekDomino's Pizza Stock Looks Cheap To Traders Who Sell Short OTM PutsCracking the Currency Code: Analyzing Seasonal Patterns and the Future of the British PoundStocks Weighed Down by Stronger U.S. PPI and Higher Bond Yields On the date of publication, Oleksandr Pylypenko did not have (either directly or indirectly) positions in any of the securities mentioned in this article. | In the coming week, investors will be monitoring a spate of economic data, including U.S. Retail Sales, Core Retail Sales, Export Price Index, Import Price Index, NY Empire State Manufacturing Index, Building Permits (preliminary), Housing Starts, Industrial Production, Manufacturing Production, Crude Oil Inventories, Philadelphia Fed Manufacturing Index, and Initial Jobless Claims. United States Steel Corporation (X) surged over +22% in pre-market trading as the company initiated a formal review of its strategic options after rejecting a $7.25 billion cash and stock takeover offer from Cleveland-Cliffs Inc. CF Industries Holdings Inc (CF) slid more than -1% in pre-market trading after Barclays downgraded the stock to Equal Weight from Overweight. More Stock Market News from Barchart Retail Data, FOMC and Other Can't Miss Items this WeekDomino's Pizza Stock Looks Cheap To Traders Who Sell Short OTM PutsCracking the Currency Code: Analyzing Seasonal Patterns and the Future of the British PoundStocks Weighed Down by Stronger U.S. PPI and Higher Bond Yields On the date of publication, Oleksandr Pylypenko did not have (either directly or indirectly) positions in any of the securities mentioned in this article.

2023-08-11

Agilent Technologies (A) to Post Q3 Earnings: What's in Store?

The Zacks Consensus Estimate for earnings is pegged at $1.37 per share, indicating growth of 2.2% from the year-ago fiscal quarter’s reported figure. The Zacks Consensus Estimate for BILI’s earnings is pegged at a quarterly loss of 41 cents per share, suggesting an increase of 45.33% from the prior-year quarter’s reported figure. Click to get this free report NVIDIA Corporation (NVDA) : Free Stock Analysis Report Agilent Technologies, Inc. (A) : Free Stock Analysis Report Workday, Inc. (WDAY) : Free Stock Analysis Report Bilibili Inc.

2023-08-10

2023-08-09

Agilent Technologies (A) Stock Moves -0.56%: What You Should Know

This industry currently has a Zacks Industry Rank of 50, which puts it in the top 20% of all 250+ industries. The Zacks Industry Rank gauges the strength of our industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Click to get this free report Agilent Technologies, Inc. (A) : Free Stock Analysis Report To read this article on Zacks.com click here.

2023-08-08